Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer, October 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 277 articles:
HTML format


 

Single Articles

  1. AGUILAR-LINARES G, Marquez-Serrano M, Meneses-Navarro S, Pelcastre-Villafuerte BE, et al
    Barriers and facilitators for adherence to follow-up by HR-HPV-positive women with premalignant cervical lesions: a mixed-design study in Mexico.
    BMC Womens Health. 2024;24:550.
    PubMed    
    Abstract available

  2. WU M, Liu R, Liu Y, Shen F, et al
    Role of HPV E7/miR-143-3p/SH2D3A pathway in regulating the occurrence and development of cervical cancer.
    J Gynecol Oncol. 2024 Sep 23. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  3. ALSHAMRANI A, Aznar M, Hoskin P, Chuter R, et al
    The Current use of Adaptive Strategies for External Beam Radiotherapy in Cervical Cancer: A Systematic Review.
    Clin Oncol (R Coll Radiol). 2024 Sep 17:S0936-6555(24)00383.
    PubMed    
    Abstract available

  4. LEE J, Ismail-Pratt I, Machalek DA, Kumarasamy S, et al
    From barriers to opportunities from COVID-19 pandemic: Stakeholder perspectives on cervical cancer screening programs in LMICs of the Asia-Pacific region.
    PLOS Glob Public Health. 2024;4:e0003768.
    PubMed    
    Abstract available

  5. ECKRICH C, Lee B, Wang C, Light K, et al
    Evaluation of cumulative dose distributions from external beam radiation therapy using CT-to-CBCT deformable image registration (DIR) for cervical cancer patients.
    J Appl Clin Med Phys. 2024 Oct 4:e14538. doi: 10.1002/acm2.14538.
    PubMed    
    Abstract available

  6. CHERIF A, Ovcinnikova O, Palmer C, Engelbrecht K, et al
    Cost-Effectiveness of 9-Valent HPV Vaccination for Patients Treated for High-Grade Cervical Intraepithelial Neoplasia in the UK.
    JAMA Netw Open. 2024;7:e2437703.
    PubMed    
    Abstract available

  7. XU F, Lai J
    Commentary: Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes.
    Front Immunol. 2024;15:1446741.
    PubMed    


  8. SHABANPOUR M, Jalali-Alhosseini P, Shoja Z, Ghafoori-Ghahdarijani F, et al
    Lineage and sublineage analysis of human papillomavirus type 58 in iranian women.
    Virol J. 2024;21:244.
    PubMed    
    Abstract available

  9. WANG F, Xu S, Zhang X, Qian Y, et al
    Squamous cell carcinoma of the cervix associated with choriocarcinomatous differentiation: a case report and review of the literature.
    J Int Med Res. 2024;52:3000605241283632.
    PubMed    
    Abstract available

  10. LI M, Zhang F, Shi Y, Shi K, et al
    Awareness of HPV and HPV vaccine among college students in China.
    Front Public Health. 2024;12:1451320.
    PubMed    
    Abstract available

  11. MONEMI M, Garrosi L, Mirzaei S, Farhadi B, et al
    Identification of proteins' expression pathway and the effective miRNAs for the treatment of human papillomavirus-induced cervical cancer: in-silico analyses-experimental research.
    Ann Med Surg (Lond). 2024;86:5784-5792.
    PubMed    
    Abstract available

  12. OU D, Cai R, Qi WX, Cui C, et al
    Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial.
    Cancer Immunol Immunother. 2024;73:244.
    PubMed    
    Abstract available

  13. HAZAZI A, Khan FR, Albloui F, Arif S, et al
    Signaling pathways in HPV-induced cervical cancer: Exploring the therapeutic promise of RNA modulation.
    Pathol Res Pract. 2024;263:155612.
    PubMed    
    Abstract available

  14. HUANG Q, Yang H, Chen L
    Recent status of cisplatin utilization in the treatment of advanced cervical cancer: A bibliometric analysis.
    Asian J Surg. 2024 Sep 30:S1015-9584(24)02190.
    PubMed    


  15. WANG H, Liu C, Jin K, Li X, et al
    Research advances in signaling pathways related to the malignant progression of HSIL to invasive cervical cancer: A review.
    Biomed Pharmacother. 2024;180:117483.
    PubMed    
    Abstract available

  16. FERGUSON SE, Brotto LA, Kwon J, Samouelian V, et al
    Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy.
    J Clin Oncol. 2024 Oct 1:JCO2400440. doi: 10.1200/JCO.24.00440.
    PubMed    
    Abstract available

  17. AHMED SR, Egemen D, Befano B, Rodriguez AC, et al
    Assessing generalizability of an AI-based visual test for cervical cancer screening.
    PLOS Digit Health. 2024;3:e0000364.
    PubMed    
    Abstract available

  18. WANG R, Harris T, Negron-Figueroa D, Lo D, et al
    Protocol for culturing patient-derived organoids of cervical cancer.
    STAR Protoc. 2024;5:103353.
    PubMed    
    Abstract available

  19. YAN A, Wu H, Jiang W
    RACK1 inhibits ferroptosis of cervical cancer by enhancing SLC7A11 core-fucosylation.
    Glycoconj J. 2024 Oct 2. doi: 10.1007/s10719-024-10167.
    PubMed    
    Abstract available

  20. LIU H, Lao M, Zhang Y, Chang C, et al
    Radiomics-based machine learning models for differentiating pathological subtypes in cervical cancer: a multicenter study.
    Front Oncol. 2024;14:1346336.
    PubMed    
    Abstract available

  21. HARDER MT, Mokete M, Chammartin F, Lerotholi M, et al
    Cervical cancer screening delay and associated factors among women with HIV in Lesotho: a mixed-methods study.
    BMC Womens Health. 2024;24:543.
    PubMed    
    Abstract available

  22. MUBTHASIMA PP, Kannan A
    Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17beta-estradiol on cancer progression.
    Med Oncol. 2024;41:255.
    PubMed    
    Abstract available

  23. RAMACHANDRAN D, Mao Q, Liao D, Kamal M, et al
    Methylation, Gene Expression, and Risk Genotypes at the TERT-CLPTM1L Locus in Cervical Cancer.
    Mol Carcinog. 2024 Oct 1. doi: 10.1002/mc.23822.
    PubMed    
    Abstract available

  24. GAO X, Kong Y, Ning Y, Tian T, et al
    The prognosis of patients with locally advanced cervical cancer undergoing surgical versus non-surgical treatment: A retrospective cohort study based on SEER database and a single-center data.
    Int J Surg. 2024 Oct 1. doi: 10.1097/JS9.0000000000002098.
    PubMed    
    Abstract available

  25. KIGURADZE E, Skhirtladze T, Chkhartishvili N, Gogoladze T, et al
    Comparison of cervical cancer screening models based on Pap and HPV tests in Tbilisi, Georgia.
    Cent Eur J Public Health. 2024;32:166-172.
    PubMed    
    Abstract available

  26. KRESIC T, Klaric M, Eminovic S, Kolobaric A, et al
    Prognostic Value of IMP3 Expression in Squamous Cervical Cancer.
    Appl Immunohistochem Mol Morphol. 2024;32:412-6.
    PubMed    
    Abstract available

  27. ZENG Z, Wang W, Yan J, Liu D, et al
    Weekly Image Guidance in Patients With Cervical Cancer Treated With Intensity-Modulated Radiation Therapy: Results of a Large Cohort Study.
    Cancer Med. 2024;13:e70269.
    PubMed    
    Abstract available

  28. ZIUKIENE GB, Liepinaitiene A
    Implementation of the cervical cancer prevention policy in one of the regions of Lithuania.
    Eur J Midwifery. 2024;8.
    PubMed    
    Abstract available

  29. WANG M, Pan Y, Zhang X, Yang R, et al
    Exploring the impact of network depth on 3D U-Net-based dose prediction for cervical cancer radiotherapy.
    Front Oncol. 2024;14:1433225.
    PubMed    
    Abstract available

  30. ZHAO Z, Ruan J, Fang M, Liu J, et al
    Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis.
    Front Immunol. 2024;15:1459693.
    PubMed    
    Abstract available

  31. KUMAR A, Varshney D, Kumar S, Saha S, et al
    An Overview of the Anticancer Potential of Silver Nanostructures against Cervical Cancer.
    Pharm Nanotechnol. 2024 Sep 27. doi: 10.2174/0122117385335239240924061439.
    PubMed    
    Abstract available

  32. JIANG W, Zhong ML, Wang SL, Chen Y, et al
    Para-aortic and pelvic lymphadenectomy in locally advanced cervical cancer with pelvic lymph node metastasis.
    World J Surg Oncol. 2024;22:262.
    PubMed    
    Abstract available

  33. LIU Y, Ai H
    Comprehensive insights into human papillomavirus and cervical cancer: Pathophysiology, screening, and vaccination strategies.
    Biochim Biophys Acta Rev Cancer. 2024;1879:189192.
    PubMed    
    Abstract available

  34. XIE W, Xu Z
    (Nano)biotechnological approaches in the treatment of cervical cancer: integration of engineering and biology.
    Front Immunol. 2024;15:1461894.
    PubMed    
    Abstract available

  35. ZHANG S, Li Q, Ouyang X, Tang Y, et al
    Radiotherapy can improve overall survival in patients with lymph-node positive, high-grade neuroendocrine cervical cancer: construction of two prognostic nomograms to predict treatment outcome.
    Front Oncol. 2024;14:1450382.
    PubMed    
    Abstract available

  36. LIU W, Huang F, Yao Y, Liang Y, et al
    Cleft lip and palate transmembrane protein 1-like is a putative regulator of tumorigenesis and sensitization of cervical cancer cells to cisplatin.
    Front Oncol. 2024;14:1440906.
    PubMed    
    Abstract available

  37. GAM S, Kumar S, Kushari S, Dutta RS, et al
    Phytochemical Screening, HPTLC Fingerprinting and Evaluation of In Vitro Cytotoxic Activity of Stem Bark Extracts of Oroxylum indicum (L.) Vent. Against Human Cervical Cancer Cells.
    Indian J Clin Biochem. 2024;39:565-571.
    PubMed    
    Abstract available

  38. ZHANG Y, Zhang Y, Pan C, Wang W, et al
    HPV-driven heterogeneity in cervical cancer: study on the role of epithelial cells and myofibroblasts in the tumor progression based on single-cell RNA sequencing analysis.
    PeerJ. 2024;12:e18158.
    PubMed    
    Abstract available

  39. BRENNAN L, Adekunle T, Kasting M, Forman MR, et al
    Factors associated with clinician willingness to adopt HPV self-sampling and self-testing for cervical cancer screening.
    J Clin Transl Sci. 2024;8:e118.
    PubMed    
    Abstract available

  40. SEBUTSOE XM, Tsotetsi NJN, Jantjies ZE, Raphela-Choma PP, et al
    Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment.
    Onco Targets Ther. 2024;17:785-801.
    PubMed    
    Abstract available

  41. GAO Y, Guo Q, Yu L
    m6A modification of RNA in cervical cancer: role and clinical perspectives.
    RNA Biol. 2024;21:49-61.
    PubMed    
    Abstract available


  42. RETRACTION: CP-31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s.
    J Cell Physiol. 2024 Sep 30. doi: 10.1002/jcp.31353.
    PubMed    
    Abstract available

  43. LIU L, Zhou Y, Lin J, Xie N, et al
    Trends in incidence and mortality for gynaecological cancers in Southeastern China during 2011-2020: a retrospective analysis of registry data.
    BMJ Open. 2024;14:e083336.
    PubMed    
    Abstract available

  44. KAGABU M, Baba T
    Enhanced immune checkpoint inhibitor therapy for advanced recurrent cervical cancer: the key to treatment efficacy and maintenance of quality of life.
    EBioMedicine. 2024;108:105386.
    PubMed    


  45. MUAFAQ SAID A, Abdulla KN, Ahmed NH, Yasin YS, et al
    Antiproliferative Impact of Linagliptin on the Cervical Cancer Cell Line.
    Asian Pac J Cancer Prev. 2024;25:3293-3300.
    PubMed    
    Abstract available

  46. AGHILI M, Babaei M, Bayani R, Jaberi R, et al
    Short Course Brachytherapy in Locally Advanced Cervical Cancer; Safety and Response Rate.
    Asian Pac J Cancer Prev. 2024;25:3119-3124.
    PubMed    
    Abstract available

  47. HAFIDZ F, Icanervilia AV, Rizal MF, Listiani P, et al
    Economic Evaluation of Cervical Cancer Screening by HPV DNA, VIA, and Pap smear Methods in Indonesia.
    Asian Pac J Cancer Prev. 2024;25:3015-3022.
    PubMed    
    Abstract available

  48. LI J, Chabaytah N, Babik J, Behmand B, et al
    Relative biological effectiveness of clinically relevant photon energies for the survival of human colorectal, cervical, and prostate cancer cell lines.
    Phys Med Biol. 2024;69.
    PubMed    
    Abstract available

  49. MATSUURA M, Tamate M, Nagao S, Akimoto T, et al
    Human papillomavirus self-sampling and urine-sampling tests and the management and short-term outcomes of cervical intraepithelial neoplasia: A prospective observational study.
    J Obstet Gynaecol Res. 2024;50:1801-1807.
    PubMed    
    Abstract available

  50. MEHTA N, Keung MHT, Pineda E, Lynn E, et al
    Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening.
    Microbiol Spectr. 2024;12:e0149324.
    PubMed    
    Abstract available

  51. DE VASCONCELOS PC, Freitas TR, de Araujo Lopes LV, Peixoto LR, et al
    RAP1-GTPase immunostaining is altered in human precancerous and cancerous cervical lesions.
    Biomark Med. 2024;18.
    PubMed    
    Abstract available

  52. BURKI T
    Continued suboptimal HPV vaccine coverage in the USA.
    Lancet Oncol. 2024;25:1257.
    PubMed    


  53. WU YW, Wei LJ, Yang X, Liang HY, et al
    Clinicopathological and immune characterization of mismatch repair deficient endocervical adenocarcinoma.
    Oncologist. 2024;29:e1302-e1314.
    PubMed    
    Abstract available

  54. WEI H, Xiong M, Min L
    Abnormal vaginal microecology can indicate cervical lesions.
    Asian J Surg. 2024;47:4560-4561.
    PubMed    


  55. LAMBERTI O, Terris-Prestholt F, Bustinduy AL, Bozzani F, et al
    A health decision analytical model to evaluate the cost-effectiveness of female genital schistosomiasis screening strategies: The female genital schistosomiasis SCREEN framework.
    Trop Med Int Health. 2024 Aug 2. doi: 10.1111/tmi.14040.
    PubMed    
    Abstract available

  56. HUANG Y, Wei X, Tu M, Lu W, et al
    CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growth.
    Cancer Sci. 2024;115:3273-3287.
    PubMed    
    Abstract available

  57. ZHANG W, Fine JL, Pei X, Cao Y, et al
    Characteristics and utility of high-resolution optical coherence microscopy images of endocervical canal lesions.
    Am J Clin Pathol. 2024;162:392-400.
    PubMed    
    Abstract available

  58. CHAO WR, Lee MY, Sheu GT, Lee YJ, et al
    HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapy.
    Naunyn Schmiedebergs Arch Pharmacol. 2024;397:7615-7622.
    PubMed    
    Abstract available

  59. XU M, Xie X, Cai L, Liu D, et al
    Preoperative scoring system for the prediction of risk of lymph node metastasis in cervical cancer.
    Sci Rep. 2024;14:23860.
    PubMed    
    Abstract available

  60. LORUSSO D, Colombo N, Dubot C, Caceres MV, et al
    Pembrolizumab Plus Chemotherapy for Advanced and Recurrent Cervical Cancer: Final Analysis According to Bevacizumab Use in the Randomized KEYNOTE-826 Study.
    Ann Oncol. 2024 Oct 9:S0923-7534(24)04033-X. doi: 10.1016/j.annonc.2024.
    PubMed    
    Abstract available

  61. DENG Z, Zhang L, Sun C, Liu Y, et al
    Identification of molecular subtypes, prognostic status and immunotherapy response in cervical cancer based on angiogenic signature genes.
    Heliyon. 2024;10:e38488.
    PubMed    
    Abstract available

  62. XIAO H, Guo Q, Ma J, Chen J, et al
    A Personalized Anisotropic Margin for Cervical Cancer Radiation Therapy Under the Guidance of Daily Iterative Cone-Beam Computed Tomography (iCBCT).
    Cureus. 2024;16:e69029.
    PubMed    
    Abstract available

  63. APOORVA, Handa V, Batra S, Arora V, et al
    Advancing epigenetic profiling in cervical cancer: machine learning techniques for classifying DNA methylation patterns.
    3 Biotech. 2024;14:264.
    PubMed    
    Abstract available

  64. YE H, Ding X, Lv X, Du Y, et al
    KLF14 directly downregulates the expression of GPX4 to exert antitumor effects by promoting ferroptosis in cervical cancer.
    J Transl Med. 2024;22:923.
    PubMed    
    Abstract available

  65. DIAS GONCALVES LIMA F, Molina MA
    Uncovering the HPV types causing cervical cancer.
    Nat Microbiol. 2024 Oct 10. doi: 10.1038/s41564-024-01835.
    PubMed    


  66. JIANG A, Chen Y, Ning Y, Yu B, et al
    MRI grading for informed clinical decision-making in Peutz-Jeghers syndrome patients with cervical lesions.
    Sci Rep. 2024;14:23731.
    PubMed    
    Abstract available

  67. CHEN X, Liu Y, Luo X, Pan T, et al
    HPV16 E6-induced M2 macrophage polarization in the cervical microenvironment via exosomal miR-204-5p.
    Sci Rep. 2024;14:23725.
    PubMed    
    Abstract available

  68. XIAO X, Wang W, Bai P, Chen Y, et al
    Genomic imprinting biomarkers for cervical cancer risk stratification.
    Cancer Commun (Lond). 2024 Oct 10. doi: 10.1002/cac2.12617.
    PubMed    


  69. KUMAR A
    C-71980262, a novel small molecule against human papilloma virus-16 E6 (HPV-16 E6) with anticancer potency against cervical cancer: A computational guided in vitro approach.
    Iran J Basic Med Sci. 2024;27:1389-1396.
    PubMed    
    Abstract available

  70. WANG Y, Zhen H, Hu K, Yu L, et al
    A phase I clinical trial evaluating the application of hydrogel in reducing rectal dose during cervical cancer brachytherapy.
    Clin Transl Radiat Oncol. 2024;49:100867.
    PubMed    
    Abstract available

  71. JIANG D, Hu X, Qi X, Liu Y, et al
    Assessment of the Incidence and Risk Factors of Stress Urinary Incontinence in Women after Cervical Cancer Surgery: A Single-Centre Retrospective Study.
    Arch Esp Urol. 2024;77:921-927.
    PubMed    
    Abstract available

  72. DRUEL V, Delpierre C, Ouanhnon L, Bugat MR, et al
    General practitioners may improve cervical screening equality in France.
    BMC Public Health. 2024;24:2748.
    PubMed    
    Abstract available

  73. XAVIER SP, da Silva KM, Galvao ND, das Neves MAB, et al
    Time to death from cervical cancer and its predictors in hospitalized patients: a survival approach study in Mato Grosso, Brazil.
    World J Surg Oncol. 2024;22:269.
    PubMed    
    Abstract available

  74. MURAKAMI A, Nomura H, Abe A, Fusegi A, et al
    Influence of COVID-19 on the clinical characteristics of patients with uterine cervical cancer in Japan: A single-center retrospective study.
    J Obstet Gynaecol Res. 2024 Oct 9. doi: 10.1111/jog.16119.
    PubMed    
    Abstract available

  75. ZENG Q, Lv C, Qi L, Wang Y, et al
    Sodium selenite inhibits cervical cancer progression via ROS-mediated suppression of glucose metabolic reprogramming.
    Life Sci. 2024;357:123109.
    PubMed    
    Abstract available

  76. NING Y, Chen Y, Tian T, Gao X, et al
    S100A7 Orchestrates Neutrophil Chemotaxis and Drives Neutrophil Extracellular Traps (NETs) Formation to Facilitate Lymph Node Metastasis in Cervical Cancer Patients.
    Cancer Lett. 2024 Oct 7:217288. doi: 10.1016/j.canlet.2024.217288.
    PubMed    
    Abstract available

  77. RADCLIFFE BA, Kim Y, Raffi J, Ayala-Peacock DN, et al
    Retrospective assessment of HDR brachytherapy dose calculation methods in locally advanced cervical cancer patients: AcurosBV vs. AAPM TG43 formalism.
    J Appl Clin Med Phys. 2024 Oct 9:e14549. doi: 10.1002/acm2.14549.
    PubMed    
    Abstract available

  78. JU M, Pan B, Huang Y, Zhou Y, et al
    The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer.
    Cancer Med. 2024;13:e70204.
    PubMed    
    Abstract available

  79. YONEDA JY, Santiago AE, Teixeira JC, Machado HC, et al
    The top hat procedure does not impact the management of women treated by LEEP in cervical cancer screening.
    Rev Bras Ginecol Obstet. 2024;46:e-rbgo44.
    PubMed    
    Abstract available

  80. ROTELI-MARTINS CM, Maranhao AGK, Fialho SCAV, da Silva-Filho AL, et al
    The importance of the quadrivalent HPV vaccine in the elimination of cervical cancer in Brazil.
    Rev Bras Ginecol Obstet. 2024;46:e-rbgoedt4.
    PubMed    


  81. AL-RAWI RA
    Early detection of cervical tumor cell of origin through Oncogene-induced senescent HPV-positive cells.
    Cell Mol Biol (Noisy-le-grand). 2024;70:129-135.
    PubMed    
    Abstract available

  82. BLOOM A, Springer R, Angier H, Heintzman J, et al
    Association Between a Mother's Cervical Cancer Screening and Child's Human Papillomavirus (HPV) Vaccination Status.
    Matern Child Health J. 2024 Oct 8. doi: 10.1007/s10995-024-03998.
    PubMed    
    Abstract available

  83. HARASANI K, Vasileva-Slaveva M, Yordanov A, Tripac I, et al
    Systematic review of cost-effectiveness studies on cervical cancer screening across Europe.
    Eur J Surg Oncol. 2024 Oct 4:108742. doi: 10.1016/j.ejso.2024.108742.
    PubMed    
    Abstract available

  84. KIM G, Viswanathan AN, Bhatia R, Landman Y, et al
    Dual convolution-transformer UNet (DCT-UNet) for organs at risk and clinical target volume segmentation in MRI for cervical cancer brachytherapy.
    Phys Med Biol. 2024 Oct 8. doi: 10.1088/1361-6560.
    PubMed    
    Abstract available

  85. TIAN Y, Zhang S, Ni F
    Targeting glucose metabolism for HPV-associated cervical cancer: A sweet poison.
    Biomed Pharmacother. 2024;180:117519.
    PubMed    
    Abstract available

  86. HUO W, Huang Y, Tian B, Chen X, et al
    Unraveling the mechanisms of RECQL4-mediated cervical cancer progression through the PI3K/AKT pathway.
    Transl Oncol. 2024;50:102146.
    PubMed    
    Abstract available

  87. OLIVER K, Shaw J, Suryadevara M, Stephens A, et al
    Optimizing Protection Against HPV-Related Cancer: Unveiling the Benefits and Overcoming Challenges of HPV Vaccination.
    Pediatr Ann. 2024;53:e372-e377.
    PubMed    
    Abstract available

  88. MODI AD, Zahid H, Southerland AC, Modi DM, et al
    Epitranscriptomics and cervical cancer: the emerging role of m(6)A, m(5)C and m(1)A RNA modifications.
    Expert Rev Mol Med. 2024;26:e20.
    PubMed    
    Abstract available

  89. SOOD T, Khandnor P, Bhatia R
    Enhancing pap smear image classification: integrating transfer learning and attention mechanisms for improved detection of cervical abnormalities.
    Biomed Phys Eng Express. 2024;10.
    PubMed    
    Abstract available

  90. ALGHALYINI B, Zaidi ARZ, Meo SA, Faroog Z, et al
    Awareness and knowledge of human papillomavirus, vaccine acceptability and cervical cancer among college students in Saudi Arabia.
    Hum Vaccin Immunother. 2024;20:2403844.
    PubMed    
    Abstract available

  91. GLEASON EG, Saris DH, Tubridy EA, Brensinger CM, et al
    Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients: Do they exist in a SEER-Medicare population?
    Gynecol Oncol Rep. 2024;55:101505.
    PubMed    
    Abstract available

  92. YASIN S, Ferede A, Tafa M
    Cervical cancer screening service utilisation and related factors among women on antiretroviral therapy in public health facilities of Asella town, Ethiopia, cross-sectional study.
    BMC Infect Dis. 2024;24:1115.
    PubMed    
    Abstract available

  93. GUO W, Hu Z, Yan J, Shen X, et al
    Epidemiological study of human papillomavirus infection in 105,679 women in Wuhan, China.
    BMC Infect Dis. 2024;24:1111.
    PubMed    
    Abstract available

  94. LIU YY, Xia M, Chen ZB, Liao YD, et al
    HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1.
    Cell Death Dis. 2024;15:732.
    PubMed    
    Abstract available

  95. RAJKHOWA P, Mathew M, Fadra R, Saha S, et al
    A scoping review of evidence on routine cervical cancer screening in South Asia: investigating factors affecting adoption and implementation.
    Cancer Causes Control. 2024 Oct 7. doi: 10.1007/s10552-024-01923.
    PubMed    
    Abstract available

  96. TANG D, Fu P, Zhao LH
    [HER2 amplification and PD-L1 expression in invasive stratified mucin-producing carcinoma of the cervix: a clinicopathological analysis of eighteen cases].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:1018-1023.
    PubMed    
    Abstract available

  97. DROLET M, Laprise JF, Chamberland E, Sauvageau C, et al
    Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis.
    CMAJ. 2024;196:E1136-E1143.
    PubMed    
    Abstract available

  98. CHEN H, Chen Y, Zheng A, Tan X, et al
    Clinical Outcomes Between Completion and Abandonment of Radical Hysterectomy in Early-Stage Cervical Cancer Patients with Lymph Nodal Involvement Identified During Surgery: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2024 Oct 7. doi: 10.1245/s10434-024-16326.
    PubMed    
    Abstract available

  99. KJAER SK, Falkenthal TEH, Sundstrom K, Munk C, et al
    Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women.
    Hum Vaccin Immunother. 2024;20:2377903.
    PubMed    
    Abstract available

  100. SOYDAL C, Baltacioglu MH, Araz M, Demir B, et al
    Prognostic Importance of (18)F-FDG Positron Emission Tomography in Uterine Cervical Cancer.
    Mol Imaging Radionucl Ther. 2024;33:167-173.
    PubMed    
    Abstract available

  101. YESHE P, Li F
    Clinical efficacy and safety of neoadjuvant chemotherapy with paclitaxel and cisplatin in combination with concurrent chemoradiotherapy for locally advanced cervical cancer: a systematic review and meta-analysis.
    J Radiat Res. 2024 Oct 5:rrae073. doi: 10.1093.
    PubMed    
    Abstract available

  102. XU J, Yang W, Xie X, Gu C, et al
    Identification of 10 differentially expressed genes involved in the tumorigenesis of cervical cancer via next-generation sequencing.
    PeerJ. 2024;12:e18157.
    PubMed    
    Abstract available

  103. CAO C, Cai D, Liu H, Zhang X, et al
    Causal relationship between genetic-predicted uric acid and cervical cancer risk: evidence for nutritional intervention on cervical cancer prevention.
    Front Nutr. 2024;11:1464046.
    PubMed    
    Abstract available

  104. SOROKIN P, Kulikova S, Nikiforchin A, Ulrikh E, et al
    Impact of Various Treatment Modalities on Long-Term Quality of Life in Cervical Cancer Survivors.
    Cureus. 2024;16:e68642.
    PubMed    
    Abstract available

  105. BRECHER AC, Handorf EA, Tan Y, Rhee J, et al
    A Community-Based Cervical Cancer Education and Navigation Program for Korean American Women.
    Asian Am J Psychol. 2024;15:196-204.
    PubMed    
    Abstract available

  106. NING K, Gong J, Li X, He L, et al
    Analysis of high-risk human papillomavirus infections and cervical intraepithelial neoplasia: factors influencing awareness among women of childbearing age in southwest China.
    Prim Health Care Res Dev. 2024;25:e41.
    PubMed    
    Abstract available

  107. HU S, Meng Y, Guo L, Xu X, et al
    A novel strategy to enhance inhibition of Hela cervical cancer by combining Lentinus beta-glucan and autophagic flux blockage.
    Int J Biol Macromol. 2024;281.
    PubMed    
    Abstract available

  108. JIN S, Xu H, Dong Y, Wang X, et al
    Ranking attention multiple instance learning for lymph node metastasis prediction on multicenter cervical cancer MRI.
    J Appl Clin Med Phys. 2024 Oct 6:e14547. doi: 10.1002/acm2.14547.
    PubMed    
    Abstract available

  109. LAL BK, Bhatta GK, Adhikari R, Karn A, et al
    Cervical Cancer Screening Services in Nepal: A Descriptive Crosssectional Study.
    JNMA J Nepal Med Assoc. 2024;62:439-445.
    PubMed    
    Abstract available

  110. LIN Y, Liu N, Yang C, Tan H, et al
    Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel.
    Virol J. 2024;21:245.
    PubMed    
    Abstract available

  111. TENG X, Chen H, Yang H, Liu H, et al
    Pre-clinical study of IR808 dye for cervical cancer in vitro and in vivo imaging.
    Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct 5. doi: 10.1007/s00210-024-03508.
    PubMed    
    Abstract available

  112. LIAO D, He Y, He B, Zeng S, et al
    Inhibiting SNX10 induces autophagy to suppress invasion and EMT and inhibits the PI3K/AKT pathway in cervical cancer.
    Clin Transl Oncol. 2024 Oct 5. doi: 10.1007/s12094-024-03715.
    PubMed    
    Abstract available

  113. SUN F, Zhao T
    KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE.
    Cancer Biomark. 2024;41:165-178.
    PubMed    
    Abstract available

  114. EL-ZEIN M, Franco EL
    Will methylation assays be part of a full molecular strategy to improve clinical management of cervical neoplasia?
    Epigenomics. 2024;16:1197-1201.
    PubMed    


  115. ZHANG X, McCluggage WG, Howitt BE, Hirsch MS, et al
    SOX17 expression in mesonephric-like adenocarcinomas and mesonephric remnants/hyperplasia of the female genital tract: Expanding its utility as a Mullerian biomarker.
    Histopathology. 2024;85:820-825.
    PubMed    
    Abstract available

  116. SATO S, Rancourt A, Satoh MS
    Cell fate simulation reveals cancer cell features in the tumor microenvironment.
    J Biol Chem. 2024;300:107697.
    PubMed    
    Abstract available

  117. YAMADA S, Orisaka M, Kurokawa T, Onuma T, et al
    Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive recurrent serous carcinoma of the uterine cervix: A case report.
    J Obstet Gynaecol Res. 2024;50:1748-1752.
    PubMed    
    Abstract available

  118. FURUNO A, Sukegawa A, Ohshige K, Suzuki Y, et al
    Three-year questionnaire study on human papillomavirus vaccination targeting new female college school students: Follow-up to a 2021 report to reveal the impact of a policy change in Japan.
    J Obstet Gynaecol Res. 2024;50:1640-1648.
    PubMed    
    Abstract available

  119. TAKAHASHI N, Seki T, Sasaki K, Machida R, et al
    High cost of chemotherapy for gynecologic malignancies.
    Jpn J Clin Oncol. 2024;54:1078-1083.
    PubMed    
    Abstract available

  120. TAMURA S, Yamanoi K, Inayama Y, Kurata Y, et al
    Investigation of the clinical implications of anterior cervical invasion in locally advanced cervical squamous cell carcinoma.
    J Obstet Gynaecol Res. 2024;50:1581-1590.
    PubMed    
    Abstract available

  121. ZOU K, Ou J
    A predictive study of genes related to lactic acid metabolism in cervical carcinoma.
    J Obstet Gynaecol Res. 2024;50:1552-1565.
    PubMed    
    Abstract available

  122. YUJING L, Sijing L, Chengli N
    Regarding "Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study".
    J Minim Invasive Gynecol. 2024;31:890-891.
    PubMed    


  123. POHLERS M, Gies S, Taenzer T, Stroeder R, et al
    Th17 cells target the metabolic miR-142-5p-succinate dehydrogenase subunit C/D (SDHC/SDHD) axis, promoting invasiveness and progression of cervical cancers.
    Mol Oncol. 2024;18:2157-2178.
    PubMed    
    Abstract available

  124. YANG C, Tan Z, Wang Y, Bi R, et al
    SwinUNeCCt: bidirectional hash-based agent transformer for cervical cancer MRI image multi-task learning.
    Sci Rep. 2024;14:24621.
    PubMed    
    Abstract available

  125. TISLER A, Vork A, Tammemagi M, Ojavee SE, et al
    Nationwide study on development and validation of a risk prediction model for CIN3+ and cervical cancer in Estonia.
    Sci Rep. 2024;14:24589.
    PubMed    
    Abstract available

  126. WU X, Sun Y, Yang H, Wang J, et al
    Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China.
    Lancet. 2024 Oct 15:S0140-6736(24)02135-4. doi: 10.1016/S0140-6736(24)02135.
    PubMed    
    Abstract available

  127. SUN C, Ma D
    Embracing more treatment choices for metastatic, recurrent, or persistent cervical cancer.
    Lancet. 2024 Oct 15:S0140-6736(24)02196-2. doi: 10.1016/S0140-6736(24)02196.
    PubMed    


  128. WEN M, Yi N, Mijiti B, Zhao S, et al
    N(6)-methyladenosine (m(6)A) reader HNRNPA2B1 accelerates the cervical cancer cells aerobic glycolysis.
    J Bioenerg Biomembr. 2024 Oct 19. doi: 10.1007/s10863-024-10042.
    PubMed    
    Abstract available

  129. VERBERCKMOES B, De Paepe E, De Vestele J, Gama A, et al
    Barriers and facilitators to cervical cancer screening among under- and neverscreened women in Flanders, Belgium - a qualitative study on community and healthcare providers' perspectives.
    BMC Public Health. 2024;24:2870.
    PubMed    
    Abstract available

  130. MELO MS, Lima SVMA, Dos Santos AD, Ribeiro CJN, et al
    Temporal trends, spatial and spatiotemporal clusters of cervical cancer mortality in Brazil from 2000 to 2021.
    Sci Rep. 2024;14:24436.
    PubMed    
    Abstract available

  131. GUO Y, Bai Y, Wang L, Xu Z, et al
    METTL3 facilitates the progression of cervical cancer by m6A modification-mediated up-regulation of NEK2.
    Sci Rep. 2024;14:24469.
    PubMed    
    Abstract available

  132. PRETET JL, Baraquin A, Chung PYJ, Puget L, et al
    The Sansure(R) Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high-risk HPV.
    J Med Virol. 2024;96:e29961.
    PubMed    
    Abstract available

  133. TAN D, Zhou C, Han S, Hou X, et al
    [Corrigendum] MicroRNA?378 enhances migration and invasion in cervical cancer by directly targeting autophagy?related protein 12.
    Mol Med Rep. 2025;31:1.
    PubMed    
    Abstract available

  134. AKOLO M, Gelmon L, Musembi H, Mutwiri B, et al
    Uptake of cervical cancer screening among sex workers living with HIV in Nairobi, Kenya: a cross-sectional study.
    Ther Adv Infect Dis. 2024;11:20499361241284238.
    PubMed    
    Abstract available

  135. MUNJOMA M, Gudukeya S, Mavudze J, Chipfumbu C, et al
    Acceptability and feasibility of implementing thermal ablation as a preventive cervical cancer treatment and the comparison of treatment outcome with cryotherapy in Zimbabwe.
    Ecancermedicalscience. 2024;18:1736.
    PubMed    
    Abstract available

  136. GUL OZTAS H, Isik K
    The Effect of Cervical Cancer Education Given to Women in Turkey on Knowledge, Attitudes, and Health Beliefs: A Randomized Controlled Study.
    Public Health Nurs. 2024 Oct 17. doi: 10.1111/phn.13456.
    PubMed    
    Abstract available

  137. IZADI N, Strmiskova J, Anton M, Hausnerova J, et al
    LAMP-based electrochemical platform for monitoring HPV genome integration at the mRNA level associated with higher risk of cervical cancer progression.
    J Med Virol. 2024;96:e70008.
    PubMed    
    Abstract available

  138. TARATULA-LYONS M, Hill MC
    Young women's perceptions of cervical screening in the UK: a qualitative study.
    Prim Health Care Res Dev. 2024;25:e49.
    PubMed    
    Abstract available

  139. MCCORMACK M, Eminowicz G, Gallardo D, Diez P, et al
    Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.
    Lancet. 2024;404:1525-1535.
    PubMed    
    Abstract available

  140. DUSKA LR, Randall LM
    Progress in the treatment paradigms for locally advanced cervical cancer.
    Lancet. 2024;404:1494-1496.
    PubMed    


  141. DUZOVA US, Kaplan Serin E, Mutlu A, Ocal N, et al
    The Effect of Cervical Cancer and Human Papillomavirus Vaccine Education on Vaccination Perception in University Students: A Quasi-Experimental Controlled Educational Intervention.
    J Adolesc Young Adult Oncol. 2024 Oct 17. doi: 10.1089/jayao.2024.0121.
    PubMed    
    Abstract available

  142. MOURA EL, Santos IFD, Freitas PP, Silva DMD, et al
    Influence of polymorphisms on the phenotype of TLR1, TLR4 and TLR9 genes and their association with cervical cancer: Bioinformatics prediction analysis and a case-control study.
    Cancer Genet. 2024;288-289:59-67.
    PubMed    
    Abstract available

  143. QI Y, Qi P, Yao Q, Sun X, et al
    Coinactivation of the Switch/Sucrose Nonfermenting Complex SMARCA4/BRG1 and SMARCB1/INI1 in a Cervical Mixed Carcinoma: A Case Report.
    Int J Gynecol Pathol. 2024;43:646-651.
    PubMed    
    Abstract available

  144. WANG X, Jiang C, Li Q
    Serinc2 Drives the Progression of Cervical Cancer Through Regulating Myc Pathway.
    Cancer Med. 2024;13:e70296.
    PubMed    
    Abstract available

  145. WANG L, Wang Y, Yang K, Hu X, et al
    Roles of microRNA-486-5p in the diagnosis and the association with clinical symptoms of cervical cancer.
    Biomark Med. 2024 Oct 17:1-8. doi: 10.1080/17520363.2024.2400963.
    PubMed    
    Abstract available

  146. XU XS, Ma YS, Dai RH, Zhang HL, et al
    Identification of novel genomic hotspots and tumor-relevant genes via comprehensive analysis of HPV integration in Chinese patients of cervical cancer.
    Am J Cancer Res. 2024;14:4665-4682.
    PubMed    
    Abstract available

  147. XING C, Ji G, Zhang D, Qin X, et al
    Construction of nomogram prediction model using heart rate and pulse perfusion variability index as predictors for hypotension in cervical cancer patients with spinal epidural anesthesia.
    Am J Cancer Res. 2024;14:4398-4410.
    PubMed    
    Abstract available

  148. WANG L, Wang Q, Zhou X, Liu H, et al
    Women's knowledge, attitude, and practice regarding cervical precancerous lesions: a cross-sectional study in Beijing, China.
    Front Public Health. 2024;12:1433718.
    PubMed    
    Abstract available

  149. LU Z, Pu T, Boning L, Ling X, et al
    Risk-stratified management of cervical high-grade squamous intraepithelial lesion based on machine learning.
    J Med Virol. 2024;96:e70016.
    PubMed    
    Abstract available

  150. MENSAH NA, Mensah YB, Dedey F
    Navigating the challenging storms of cancer management in a national cancer centre: perspectives of female patients.
    BMC Public Health. 2024;24:2856.
    PubMed    
    Abstract available

  151. ALSAIARI AA, Almufarriji FM, Hazazi A, Almarghalani DA, et al
    Multitargeted docking approach reveals droxidopa against DNA replication and repair-related protein of cervical cancer.
    Sci Rep. 2024;14:24301.
    PubMed    
    Abstract available

  152. LIAO Y, Ye L, Cai Q, Song H, et al
    Status and influencing factors of knowledge, attitudes and practices relating to screening for breast and cervical cancer among rural women aged 40-65 years in China: a cross-sectional study.
    BMJ Open. 2024;14:e080945.
    PubMed    
    Abstract available

  153. TEIGNE D, Banaszuk AS, Grimault C, Lebon A, et al
    Organized cervical cancer screening: A randomized controlled trial assessing the effect of sending invitation letters.
    Prev Med. 2024;189:108150.
    PubMed    
    Abstract available

  154. SAHU B, Thakur M, Shapeti SS
    Anxiety and depression among those experiencing cervical cancer in India: A neglected theme for research.
    J Cancer Res Ther. 2024;20:1664-1665.
    PubMed    


  155. OPPONG AF, Nwozichi CU, Boakye EO, Kyei EF, et al
    Characterizing the Patterns of Cervical Cancer Symptom Recognition, Symptom Response, and Associated Factors Among Patients Treated in a Teaching Hospital in Ghana.
    Cancer Nurs. 2024 Oct 11. doi: 10.1097/NCC.0000000000001411.
    PubMed    
    Abstract available

  156. GARG M, Bhati P, Balaji G, Sasidharan A, et al
    Hematological Parameters at Baseline: A Novel Prognostic Factor for Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy in South India.
    Cureus. 2024;16:e69461.
    PubMed    
    Abstract available

  157. SHAO Y, Shah PT, Su Q, Li S, et al
    Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells.
    Front Cell Infect Microbiol. 2024;14:1459572.
    PubMed    
    Abstract available

  158. HAN L, Chen Y, Zheng A, Tan X, et al
    Stage migration and survival outcomes in patients with cervical cancer at Stage IIIC according to the 2018 FIGO staging system: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1460543.
    PubMed    
    Abstract available

  159. TOZZI R, Bigardi S, Spagnol G, Ferrari F, et al
    Nerve-Sparing Laparoscopic Radical Hysterectomy (nsLRH) without Adjuvant Therapy in FIGO Stage IB3 Cervical Cancer Patients: Surgical Technique and Survival Outcomes.
    Cancers (Basel). 2024;16:3355.
    PubMed    
    Abstract available

  160. GAXIOLA-RUBIO A, Jave-Suarez LF, Hernandez-Silva CD, Ramirez-de-Arellano A, et al
    The G-Protein-Coupled Estrogen Receptor Agonist G-1 Mediates Antitumor Effects by Activating Apoptosis Pathways and Regulating Migration and Invasion in Cervical Cancer Cells.
    Cancers (Basel). 2024;16:3292.
    PubMed    
    Abstract available

  161. PANDEY P, Ramniwas S, Pandey S, Lakhanpal S, et al
    Review to Elucidate the Correlation between Cuproptosis-Related Genes and Immune Infiltration for Enhancing the Detection and Treatment of Cervical Cancer.
    Int J Mol Sci. 2024;25:10604.
    PubMed    
    Abstract available

  162. PUTRA AD, Andrijono, Winarto H, Prijanti AR, et al
    miR-21 and miR-145 as Prognostic Biomarkers for Radiotherapy Responses in Cervical Cancer Patients: A Preliminary Study.
    Int J Mol Sci. 2024;25:10545.
    PubMed    
    Abstract available

  163. PAVONE G, Marino A, Fisicaro V, Motta L, et al
    Entangled Connections: HIV and HPV Interplay in Cervical Cancer-A Comprehensive Review.
    Int J Mol Sci. 2024;25:10358.
    PubMed    
    Abstract available

  164. LUO J, He L, Guo Y, Wang J, et al
    MCPIP1 Elicits a Therapeutic Effect on Cervical Cancer by Facilitating XIAP mRNA Decay via Its Endoribonuclease Activity.
    Int J Mol Sci. 2024;25:10285.
    PubMed    
    Abstract available

  165. RANTSHABENG PS, Tsima BM, Ndlovu AK, Motlhatlhedi K, et al
    High-risk human papillomavirus diversity among indigenous women of western Botswana with normal cervical cytology and dysplasia.
    BMC Infect Dis. 2024;24:1163.
    PubMed    
    Abstract available

  166. JIN K, Zhao D, Zhou J, Zhang X, et al
    Pulsed electromagnetic fields inhibit IL-37 to alleviate CD8(+) T cell dysfunction and suppress cervical cancer progression.
    Apoptosis. 2024 Oct 15. doi: 10.1007/s10495-024-02006.
    PubMed    
    Abstract available

  167. WANG R, Zhang Y
    RecQ protein-like 4 drives cisplatin chemosensitivity of cervical cancer cells by modulating annexin A2.
    Drug Dev Res. 2024;85:e70003.
    PubMed    
    Abstract available

  168. LESTARI DPO, Wellere AI, Brill IK, Sari NLPEK, et al
    The Impact of an Educational Program on Cervical Cancer Knowledge Among HIV-Positive Women in Bali, Indonesia.
    Int J Womens Health. 2024;16:1677-1685.
    PubMed    
    Abstract available

  169. NI H, Huang C, Ran Z, Li S, et al
    Targeting HPV for the prevention, diagnosis, and treatment of Cervical Cancer.
    J Mol Cell Biol. 2024 Oct 14:mjae046. doi: 10.1093.
    PubMed    
    Abstract available

  170. WU Z, Wang D, Xu C, Peng S, et al
    Clinical target volume (CTV) automatic delineation using deep learning network for cervical cancer radiotherapy: A study with external validation.
    J Appl Clin Med Phys. 2024 Oct 14:e14553. doi: 10.1002/acm2.14553.
    PubMed    
    Abstract available

  171. CHENG L, Wang R, Yan J
    A review of urinary HPV testing for cervical cancer management and HPV vaccine surveillance: rationale, strategies, and limitations.
    Eur J Clin Microbiol Infect Dis. 2024 Oct 14. doi: 10.1007/s10096-024-04963.
    PubMed    
    Abstract available

  172. YANG LL, Zhang XK, Cao Y, Shi LY, et al
    PARP1 acetylation at K119 is essential in regulating the progression and proliferation of cervical cancer cells.
    Med Oncol. 2024;41:273.
    PubMed    
    Abstract available

  173. OLTHOF EMG, Kaljouw S, van Kemenade FJ, Uyterlinde AM, et al
    Cost-Effectiveness of Computer-Assisted Cytology in a Primary hrHPV-Based Cervical Cancer Screening Programme.
    Cancer Med. 2024;13:e70299.
    PubMed    
    Abstract available

  174. BALAMOU C, Zysman K, Olicard C, Garnier A, et al
    Prevalence and Description of High-Grade Intraepithelial Lesions of Cervical Mucosa Cells in a Screening Programme for Cervical Cancer in Isere, France.
    Cancer Med. 2024;13:e70259.
    PubMed    
    Abstract available

  175. NUSSBAUM L, Brown J, Meza-Sanchez G, Soto S, et al
    Catalyzing Change: Assessing Inner Setting Context of Cervical Cancer Prevention Efforts in Loreto, Peru, Prior to Transition from VIA to HPV Screen-and-Treat.
    Res Sq [Preprint]. 2024 Sep 27:rs.3.rs-4992569. doi: 10.21203/rs.3.rs-4992569.
    PubMed    
    Abstract available

  176. CETINA-PEREZ L, Medina-Contreras O
    Editorial: Cervical cancer: updates from the Mexican national consensus.
    Front Oncol. 2024;14:1493334.
    PubMed    


  177. LEDWABA L, Saidu R, Malila B, Kuhn L, et al
    Automated analysis of digital medical images in cervical cancer screening: A systematic review.
    medRxiv [Preprint]. 2024 Sep 27:2024.09.27.24314466.
    PubMed    
    Abstract available

  178. NISHINO S, Yunokawa M, Matsuura Y, Fusegi A, et al
    Secondary spontaneous pneumothorax during chemotherapy with bevacizumab for cervical cancer: a case report and literature review.
    Int Cancer Conf J. 2024;13:395-400.
    PubMed    
    Abstract available

  179. OKPALANWAKA IF, Anazodo FI, Chike-Aliozor ZL, Ekweozor C, et al
    Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa.
    Cureus. 2024;16:e69136.
    PubMed    
    Abstract available

  180. GANDHI R, Patel A, Patel M, Sojitra SA, et al
    Cervical Cancer Prevention Among Rural Women in Gujarat, India: A Mixed Methods Study on Risk Factors and KAP (Knowledge, Attitude and Practice).
    Cureus. 2024;16:e69169.
    PubMed    
    Abstract available

  181. LIU D, Chu J
    Analysis of effectiveness in an artificial intelligent film reading system combined with liquid based cytology examination for cervical cancer screening.
    Am J Transl Res. 2024;16:4979-4987.
    PubMed    
    Abstract available

  182. OKABA E
    Knowledge, Attitude and Practice Concerning Cervical Cancer Screening Among Reproductive Age Group Women in Low-Resource Settings Yenagoa Bayelsa State.
    Niger Med J. 2024;65:512-523.
    PubMed    
    Abstract available

  183. LI MY, Liu JQ, Chen DP, Li ZY, et al
    [Retracted] p68 prompts the epithelial?mesenchymal transition in cervical cancer cells by transcriptionally activating the TGF?beta1 signaling pathway.
    Oncol Lett. 2024;28:575.
    PubMed    
    Abstract available

  184. MOMBO-MAGANGA C, Mangala C, Mabika-Obanda AKF, Maulot-Bangola D, et al
    Prevalence of high-risk human papillomavirus genotypes and viral load correlated with squamous cell inflammation among women in Gabon.
    BMC Womens Health. 2024;24:561.
    PubMed    
    Abstract available

  185. THRALL MJ, McCarthy E, Mito JK, Rao J, et al
    Triage options for positive high-risk HPV results from HPV-based cervical cancer screening: a review of the potential alternatives to Papanicolaou test cytology.
    J Am Soc Cytopathol. 2024 Sep 19:S2213-2945(24)00213.
    PubMed    
    Abstract available

  186. TAMANG P, Gupta M, Thatal A
    Digital colposcopy image analysis techniques requirements and their role in clinical diagnosis: a systematic review.
    Expert Rev Med Devices. 2024;21:955-969.
    PubMed    
    Abstract available

  187. SYED KHAJA AS, Saleem M, Zafar M, Moursi S, et al
    Association between pelvic inflammatory disease and risk of ovarian, uterine, cervical, and vaginal cancers-a meta-analysis.
    Arch Gynecol Obstet. 2024;310:2577-2585.
    PubMed    
    Abstract available

  188. GOODMAN E, Reuschenbach M, Viering T, Luzak A, et al
    The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances.
    Arch Gynecol Obstet. 2024;310:2639-2646.
    PubMed    
    Abstract available

  189. PANJI Z, Nadoushan MJ, Fekrirad Z, Rasooli I, et al
    Modulation with anti-Oma87 antibodies of cytotoxicity, adherence, and internalization of Acinetobacter baumannii in human cervical carcinoma epithelial cells.
    APMIS. 2024;132:843-858.
    PubMed    
    Abstract available

  190. FERNANDEZ-DEAZA G, Negrete-Tobar G, Caicedo M, Tellez N, et al
    Cervical precancer and invasive cancer among women living with HIV in Latin America: A systematic review and meta-analysis.
    Int J STD AIDS. 2024;35:1008-1018.
    PubMed    
    Abstract available

  191. QIN J, He Y, Liang Y, Kang L, et al
    Cell comparative learning: A cervical cytopathology whole slide image classification method using normal and abnormal cells.
    Comput Med Imaging Graph. 2024;117:102427.
    PubMed    
    Abstract available

  192. ZHANG C, Yuan L, Wen W, Shao C, et al
    LNMAC Promotes Cervical Squamous Cell Carcinoma Lymphatic Metastasis via Epigenetic Regulation of FGF2-Induced Lymphangiogenesis.
    Adv Sci (Weinh). 2024;11:e2404645.
    PubMed    
    Abstract available

  193. YANG J, Peng Y, Ding Y, Liu Y, et al
    The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target.
    Mod Pathol. 2024;37:100569.
    PubMed    
    Abstract available

  194. ALTMANN J, Kubiak K, Sehouli J, Roser E, et al
    Fertility-sparing strategy in a rare case of highly malignant Dicer-1-associated sarcoma of the cervix.
    Arch Gynecol Obstet. 2024;310:2617-2621.
    PubMed    
    Abstract available

  195. CHEN Y, He H, Wang X, Ye Y, et al
    Influence of cervical treatment methods on subsequent vaginal lesions: A study of HPV-related neoplasia.
    Biomol Biomed. 2024;24:1595-1605.
    PubMed    
    Abstract available

  196. DAVIES JC, Sargent A, Pinggera E, Carter S, et al
    Urine high-risk human papillomavirus testing as an alternative to routine cervical screening: A comparative diagnostic accuracy study of two urine collection devices using a randomised study design trial.
    BJOG. 2024;131:1456-1464.
    PubMed    
    Abstract available

  197. GAGRANI V, Kabara J, Shukla A, Rathore NK, et al
    A comparative study between two different dose fractionation schedules of cobalt-60-based HDR intracavitary brachytherapy in carcinoma cervix stages IIB-IIIC1.
    J Cancer Res Ther. 2024;20:1551-1556.
    PubMed    
    Abstract available

  198. YEARY KHK, Willis DE, Yu H, Johnson B, et al
    Self-reported Racial Discrimination and Healthy Behaviors in Black Adults Residing in Rural Persistent Poverty Areas.
    J Racial Ethn Health Disparities. 2024;11:2756-2765.
    PubMed    
    Abstract available

  199. GARCIA E, Ayoub N, Tewari KS
    Erratum: Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer.
    J Gynecol Oncol. 2024 Oct 18. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  200. KWON JS, McTaggart-Cowan H, Ferguson SE, Samouelian V, et al
    Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.
    J Gynecol Oncol. 2024 Oct 18. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  201. SO YL, He MY, Hui SK, Yu EL, et al
    Clinical trial comparing the use of Orcellex((R)) Brush versus Cervex-Brush((R)) on vaginal vault smear cytology adequacy rate in patients treated with radiotherapy for cervical cancer.
    J Gynecol Oncol. 2024 Oct 22. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  202. PEREZ S
    Progress and Challenges in Canada's Path Toward the Elimination of Cervical Cancer.
    Curr Oncol. 2024;31:5850-5861.
    PubMed    
    Abstract available

  203. MOHAMMED FA, Tune KK, Mohammed JA, Wassu TA, et al
    Early Cervical Cancer Diagnosis with SWIN-Transformer and Convolutional Neural Networks.
    Diagnostics (Basel). 2024;14:2286.
    PubMed    
    Abstract available

  204. SALAMI BO, Kalenga CZ, Olukotun M, Renzaho AMN, et al
    Ethnic and racialized disparities in the use of screening services for pap smears and mammograms in Canada.
    Cancer Med. 2024;13:e70021.
    PubMed    
    Abstract available

  205. WANG M, Chen H, Wong MCS, Huang J, et al
    Effects of screening coverage and screening quality assurance on cervical cancer mortality: Implication for integrated framework to monitor global implementation of cervical cancer screening programmes.
    J Glob Health. 2024;14:04189.
    PubMed    
    Abstract available

  206. MASEKO TN, Tsoka-Gwegweni JM, Dlamini X
    "A Man With a Loving Heart": A Systematic Review of Male Involvement in Cervical Cancer Screening in Africa.
    Int J Public Health. 2024;69:1607447.
    PubMed    
    Abstract available

  207. YU T, Gao S, Jin F, Yan B, et al
    Characteristics of the vaginal microbiota and vaginal metabolites in women with cervical dysplasia.
    Front Cell Infect Microbiol. 2024;14:1457216.
    PubMed    
    Abstract available

  208. WANG C, Cai Y, Feng P
    Case report: A case of sintilimab-induced recurrent diabetic ketoacidosis and thyroid dysfunction in a patient with advanced cervical carcinoma.
    Front Immunol. 2024;15:1405856.
    PubMed    
    Abstract available


  209. Retraction: long noncoding RNA ANRIL promotes cervical cancer development by acting as a sponge of miR-186.
    Oncol Res. 2024;32:1817.
    PubMed    
    Abstract available

  210. YAN Q, Wu M, Zhang J, Yang J, et al
    MRI radiomics and nutritional-inflammatory biomarkers: a powerful combination for predicting progression-free survival in cervical cancer patients undergoing concurrent chemoradiotherapy.
    Cancer Imaging. 2024;24:144.
    PubMed    
    Abstract available

  211. CENA SE, Olivero F, Martini S, Gianello L, et al
    External beam radiotherapy followed by image-guided adaptive brachytherapy in locally advanced cervical cancer: a multicenter retrospective analysis.
    Radiol Med. 2024 Oct 24. doi: 10.1007/s11547-024-01899.
    PubMed    
    Abstract available

  212. HERNANDEZ ND, Wilson N, Abah T, Contreras O, et al
    Unveiling Cervical Cancer Inequities Among Georgia Immigrant Latinas: A Robust Qualitative Examination of the Facilitators and Barriers to Prevention, with Emphasis on the Impact of Community-Based Organizations.
    J Cancer Educ. 2024 Oct 25. doi: 10.1007/s13187-024-02532.
    PubMed    
    Abstract available

  213. STRAATHOF R, van Vliet-Perez SM, Kolkman-Deurloo IK, Wauben LSGL, et al
    Automated planning of curved needle channels in 3D printed patient-tailored applicators for cervical cancer brachytherapy.
    Phys Med Biol. 2024 Oct 24. doi: 10.1088/1361-6560.
    PubMed    
    Abstract available

  214. MA Z, Xiang X, Chai Y, Wang J, et al
    The application value of low-risk human papillomavirus testing in cervical cancer prevention and treatment in low- and middle-resource areas.
    Public Health. 2024;237:205-211.
    PubMed    
    Abstract available

  215. REITER PL, Shoben AB, Cooper S, Ashcraft AM, et al
    A Mail-Based HPV Self-Collection Program to Increase Cervical Cancer Screening in Appalachia: Results of a Group Randomized Trial.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed    
    Abstract available

  216. YANG Y, Zhang L, Hartwig S, Jiang P, et al
    Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China.
    Hum Vaccin Immunother. 2024;20:2418168.
    PubMed    
    Abstract available

  217. HUNTINGTON S, Smith JS, Nuttall D, Polokaova A, et al
    Evidence from Europe on implementation, participation and performance of self-collection for cervical cancer screening.
    Future Oncol. 2024 Oct 24:1-12. doi: 10.1080/14796694.2024.2409625.
    PubMed    
    Abstract available

  218. LOU J, Guo F
    The characteristics of high-risk HPV-negative cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1452834.
    PubMed    
    Abstract available

  219. SHAO L, Liu W, Zhang C, Ma W, et al
    The Role and Function of Secretory Protein Matrix Metalloproteinase-3 (MMP3) in Cervical Cancer.
    Iran J Public Health. 2024;53:855-866.
    PubMed    
    Abstract available

  220. WHITE LL, Goldberg SR, Escobar AG, Hixon B, et al
    Cervical Cancer Screening: Patient Perspectives on Transitioning to Primary High-Risk Human Papillomavirus Testing Alone.
    Perm J. 2024 Oct 24:1-8. doi: 10.7812.
    PubMed    
    Abstract available

  221. CORAZZELLI G, Zanuttini L, Balestrini D, Quercia S, et al
    Strategic insights and survival outcomes: a systematic review of CNS metastases in uterine cervical cancer.
    Br J Neurosurg. 2024 Oct 23:1-14. doi: 10.1080/02688697.2024.2418490.
    PubMed    
    Abstract available

  222. ZHANG H, Li X, Yang Z, Gao R, et al
    Influence of COVID-19 pandemic on prevalence and genotype distribution of HPV in cervical cancer screening population.
    Virol J. 2024;21:261.
    PubMed    
    Abstract available

  223. VAN WELL EB, Showalter TN, Giannouli S, Nioutsikou E, et al
    The effect of one-room CT guided brachytherapy on procedure time and cost in the treatment of cervical cancer.
    Brachytherapy. 2024 Oct 22:S1538-4721(24)00390.
    PubMed    
    Abstract available

  224. FENG Y, Sun Z, Zhang H, Wang Z, et al
    Plasma-based proteomic and metabolomic characterization of lung and lymph node metastases in cervical cancer patients.
    J Pharm Biomed Anal. 2024;253:116521.
    PubMed    
    Abstract available

  225. CHEN JJ, Sarkar IN, Hsu E, Dizon DS, et al
    An Intersectional Approach to Cervical Cancer Screening Disparities by Race/Ethnicity and Immigrant Status.
    J Womens Health (Larchmt). 2024 Oct 23. doi: 10.1089/jwh.2024.0251.
    PubMed    
    Abstract available

  226. TER-MINASYAN V
    EVALUATION OF KNOWLEDGE AND ATTITUDE REGARDING CERVICAL CANCER SCREENING PRACTICE: A MULTICENTER REGIONAL STUDY.
    Georgian Med News. 2024;.
    PubMed    
    Abstract available

  227. SOLDAN K, Falcaro M, Sasieni P
    HPV vaccination has dramatically reduced inequalities in cervical cancer, but the most deprived groups remain at highest risk.
    BMJ. 2024;387:q2296.
    PubMed    


  228. JIA X, Jiang M, Zhou J, Ma C, et al
    Trends in high-risk human papillomavirus infection and cervical cytology of women in Karamay City, 2012-2021.
    Sex Health. 2024;21:SH24057.
    PubMed    
    Abstract available

  229. WILLIAMS C, Goulbourne E, Gyansa E, Hashi A, et al
    Initiatives to increase breast and cervical cancer-related knowledge, screening, and health behaviours among Black women.
    Can J Public Health. 2024 Oct 22. doi: 10.17269/s41997-024-00953.
    PubMed    
    Abstract available

  230. DAI W, Guo C, Yang Q, Zhang Y, et al
    Validation of the 2019 American Society of Colposcopy and Cervical Pathology Online Cervical Cancer Screening Program via 9 Large-Cohort Data of Chinese Women.
    J Low Genit Tract Dis. 2024 Oct 22. doi: 10.1097/LGT.0000000000000852.
    PubMed    
    Abstract available

  231. AL-HINDAWI MM
    Prevalence of cervical dysplastic lesions in cervical smears from Baghdad city: a single centre study.
    J Pak Med Assoc. 2024;74.
    PubMed    
    Abstract available

  232. MEDA ZC, Hien H, Traore TI, Ouattara CA, et al
    Factors associated with positive human papillomavirus (HPV) test results in cervical precancer screening: a cross-sectional study at Souro Sanou National Teaching Hospital (SSNTH) in Bobo Dioulasso, Burkina Faso.
    BMC Public Health. 2024;24:2900.
    PubMed    
    Abstract available

  233. FOURIE L, Christowitz C, Eksteen C, van der Merwe H, et al
    Inflammation and thrombotic risk in late-stage cervical cancer: An exploratory study of coagulation and cytokine profiles in a South African cohort.
    Cytokine. 2024;184:156782.
    PubMed    
    Abstract available

  234. ALSHAHRANI NZ, Alshahrani JA, Almushari BS, Alshammri FM, et al
    Parental Perspectives on Human Papillomavirus (HPV) Vaccination in Gulf Cooperation Council Countries: A systematic review.
    Medicine (Baltimore). 2024;103:e40124.
    PubMed    
    Abstract available

  235. SHI Y, Xu Y, Li M, Zheng W, et al
    Cervical angiofibroma of soft tissue: A rare case report with literature review.
    Medicine (Baltimore). 2024;103:e40200.
    PubMed    
    Abstract available

  236. KALANI M, Mirzaei F, Keyghobadi H, Keighobadi G, et al
    Comparing the distribution of common human papillomavirus genotypes among the population of Fars province in southwest Iran with the genotypes included in the available HPV vaccines.
    Mol Biol Rep. 2024;51:1083.
    PubMed    
    Abstract available

  237. ETEMAD S, Asghari Baghalan AM, Naeimi B, Mehrzad S, et al
    Prevalence of Human Papillomavirus (HPV) Infection and its Association With Pap Smear Findings Among Women Attending a Gynecology Clinic in Khorasan Razavi-Iran.
    J Res Health Sci. 2024;24:e00629.
    PubMed    
    Abstract available

  238. HAO Q, Feng L, Chen D, Fan X, et al
    Application of WeChat-based cognitive behavioural stress management for early-stage cervical cancer patients: a randomised controlled study.
    J Obstet Gynaecol. 2024;44:2410858.
    PubMed    
    Abstract available

  239. SON J, Cain KE, Marten CA, Dwyer KW, et al
    Tisotumab vedotin extravasation injury in a patient with recurrent cervical cancer.
    Gynecol Oncol Rep. 2024;56:101525.
    PubMed    
    Abstract available

  240. GYMAH GYAMFI H
    Impact of gender and education on cervical cancer knowledge amongst students: implications for health policies and public health strategies in Wiesbaden, Germany.
    J Prev Med Hyg. 2024;65:E227-E231.
    PubMed    
    Abstract available

  241. MAHAJAN I, Kadam A, McCann L, Ghose A, et al
    Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer.
    Ecancermedicalscience. 2024;18:1762.
    PubMed    
    Abstract available

  242. DIAZ JFR
    Hemoglobin level and survival in cervical cancer with chemoradiotherapy at high altitude, 2020-2022.
    Ecancermedicalscience. 2024;18:1767.
    PubMed    
    Abstract available

  243. HONG R, Luo L, Xu X, Huang K, et al
    The treatment response evaluation through the combination of contrast-enhanced ultrasound and squamous cell carcinoma antigen in cervical cancer.
    Quant Imaging Med Surg. 2024;14:7587-7599.
    PubMed    
    Abstract available

  244. SU Y, Zeng K, Yan Z, Yang X, et al
    Predicting the Ki-67 proliferation index in cervical cancer: a preliminary comparative study of four non-Gaussian diffusion-weighted imaging models combined with histogram analysis.
    Quant Imaging Med Surg. 2024;14:7484-7495.
    PubMed    
    Abstract available

  245. MA C, Zhou J
    First Application of Demand-Triggered Online Adaptive Radiotherapy in the Treatment of Cervical Cancer: A Clinical Report.
    Cureus. 2024;16:e69703.
    PubMed    
    Abstract available

  246. KASHYAP VK, Nagesh PKB, Singh AK, Massey A, et al
    Curcumin attenuates smoking and drinking activated NF-kappaB/IL-6 inflammatory signaling axis in cervical cancer.
    Cancer Cell Int. 2024;24:343.
    PubMed    
    Abstract available

  247. CHEN L, Wu L, Huang Q
    Exploring the effectiveness of Neoadjuvant chemotherapy in cervical cancer: A bibliometric approach.
    Asian J Surg. 2024 Oct 19:S1015-9584(24)02294.
    PubMed    


  248. PAN CH, Xu XQ, Wen TM, Wang MY, et al
    [Evaluation of the 10-year protective effect and immunogenicity of quadrivalent HPV vaccination].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2024;58:1508-1513.
    PubMed    
    Abstract available

  249. LI L, Su Y
    Mediation Effects of Self-Care Self-Efficacy and Health-Promoting Behaviors on Fear of Cancer Recurrence and Posttraumatic Growth in Postoperative Patients with Cervical Cancer: A Cross-Sectional Study.
    Asian Nurs Res (Korean Soc Nurs Sci). 2024 Oct 18:S1976-1317(24)00110.
    PubMed    
    Abstract available

  250. GONZALEZ PENA T, Huang M
    Genetic Predisposition for Gynecologic Cancers.
    Clin Obstet Gynecol. 2024;67:660-665.
    PubMed    
    Abstract available

  251. GOKKAYA M, Alci A, Aytekin O, Unsal M, et al
    Does HPV-18 co-infection increase the risk of cervical pathology in individuals with HPV-16?
    Cytopathology. 2024;35:757-760.
    PubMed    
    Abstract available

  252. WENZEL HHB, Schnack TH, Van der Aa MA, Jensen PT, et al
    Risk factors for lymph node metastasis in women with FIGO 2018 IA cervical cancer with a horizontal spread of > 7 mm.
    Eur J Cancer. 2024;212:115063.
    PubMed    
    Abstract available

  253. MCGEE AE, Hawco S, Bhattacharya S, Hanley SJB, et al
    Alternatives to surveillance for persistent human papillomavirus after a positive cervical screen: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:332-338.
    PubMed    
    Abstract available

  254. COBBINAH P, Zheng Zheng S, Oklah F, Yuyang Z, et al
    Comparative analysis of Paiteling a traditional Chinese medicine (TCM) and CO2 laser therapy for high-risk HPV-associated with LSIL (CIN1) lesions.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:81-86.
    PubMed    
    Abstract available

  255. NG ZY, Manchanda R, Lopez A, Obermair A, et al
    The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study.
    Gynecol Oncol. 2024;191:95-99.
    PubMed    
    Abstract available

  256. LI G, Li X, Yin R, Feng M, et al
    Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer.
    Gynecol Oncol. 2024;191:165-171.
    PubMed    
    Abstract available

  257. ELAYAPILLAI SP, Dogra S, Lausen J, Parker M, et al
    ATR inhibition increases reliance on PARP-mediated DNA repair revealing an improved therapeutic strategy for cervical cancer.
    Gynecol Oncol. 2024;191:182-193.
    PubMed    
    Abstract available

  258. MISHRA GA, Pimple SA, Anand KV, Kulkarni VY, et al
    Acceptability and validity of HPV self-sampling for cervical cancer screening among women living in different ecological settings in India.
    Int J Cancer. 2024 Oct 16. doi: 10.1002/ijc.35222.
    PubMed    
    Abstract available

  259. LEHTINEN M, Elfstrom M, Vanska S, Dillner J, et al
    Elimination of cervical cancer by refined vaccination and screening.
    Int J Cancer. 2024 Oct 25. doi: 10.1002/ijc.35228.
    PubMed    


  260. KOKEMULLER L, Ramachandran D, Schurmann P, Geffers R, et al
    Germline variants of homology-directed repair or mismatch repair genes in cervical cancer.
    Int J Cancer. 2024 Oct 23. doi: 10.1002/ijc.35221.
    PubMed    
    Abstract available

  261. SADAT R, Sacinti KG, Topcu EG, Saeed S, et al
    Overcoming barriers to cervical cancer prevention in Afghanistan: The imperative for an HPV vaccination and screening program.
    Int J Gynaecol Obstet. 2024 Oct 16. doi: 10.1002/ijgo.15956.
    PubMed    


  262. SILVA FILHO ALD, Reis Romualdo G, Pinhati MES, Neves GL, et al
    Exploring cervical cancer mortality in Brazil: an ecological study on socioeconomic and healthcare factors.
    Int J Gynecol Cancer. 2024 Oct 4:ijgc-2024-005738. doi: 10.1136/ijgc-2024-005738
    PubMed    
    Abstract available

  263. GOLIA D'AUGE T, Caruso G, Laudani ME, Nazzaro L, et al
    Para-aortic lymph node recurrence in surgically treated early-stage cervical cancer without para-aortic lymph node surgical staging.
    Int J Gynecol Cancer. 2024 Oct 8:ijgc-2024-005950. doi: 10.1136/ijgc-2024-005950
    PubMed    
    Abstract available

  264. GOUVEIA MC, Graziano LM, Leis LV, Scaranti M, et al
    The evolving landscape of locally advanced cervical cancer treatment.
    Int J Gynecol Cancer. 2024 Oct 7:ijgc-2024-006128. doi: 10.1136/ijgc-2024-006128
    PubMed    


  265. PAN TL, Pareja R, Chiva L, Rodriguez J, et al
    Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancer.
    Int J Gynecol Cancer. 2024 Oct 23:ijgc-2024-005986.
    PubMed    
    Abstract available

  266. AFROZE L, Rahman MS
    Community-based interventions to reduce cervical cancer in low- and middle-income countries: a call to action.
    Int J Gynecol Cancer. 2024 Oct 21:ijgc-2024-006188.
    PubMed    


  267. FENG L, Shi Q, Wang S, Zhao Y, et al
    The outcome of advanced and recurrent cervical cancer patients treated with first-line platinum and paclitaxel with or without indication for immune checkpoint inhibitors: the comparative study.
    BMC Cancer. 2024;24:1267.
    PubMed    
    Abstract available

  268. LI M, Xu T, Yang R, Wang X, et al
    Exploring MPC1 as a potential ferroptosis-linked biomarker in the cervical cancer tumor microenvironment: a comprehensive analysis.
    BMC Cancer. 2024;24:1258.
    PubMed    
    Abstract available

  269. RASEKHI KAZERUNI A, Babaei N, Esmaeili Gouvarchin Ghaleh H, Doosti A, et al
    Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model.
    BMC Cancer. 2024;24:1253.
    PubMed    
    Abstract available

  270. YIRSAW AN, Tefera M, Bogale EK, Anagaw TF, et al
    Applying the Health Belief Model to cervical cancer screening uptake among women in Ethiopia: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:1294.
    PubMed    
    Abstract available

  271. TURNA M, Rzazade R, Kucukmorkoc E, Kucuk N, et al
    Dose escalation with stereotactic body radiotherapy for cervical cancer treatment.
    BMC Cancer. 2024;24:1281.
    PubMed    
    Abstract available

  272. MEKONEN EG, Gebrehana DA, Tamir TT
    Determinants of cervical cancer screening among women of childbearing age in four sub-Saharan African countries: insights from large population surveys.
    BMC Cancer. 2024;24:1304.
    PubMed    
    Abstract available

  273. DANTAS DM, de Souza ATB, de Araujo Santos Camargo JD, Costa APF, et al
    Efficacy and safety of pembrolizumab in cervical cancer: Protocol for systematic review and meta-analysis of randomized clinical trials.
    PLoS One. 2024;19:e0312004.
    PubMed    
    Abstract available

  274. TWABI HH, Msosa TC, Meja SJ, Mukoka M, et al
    Spatial distribution and characteristics of women reporting cervical cancer screening in Malawi: An analysis of the 2020 to 2021 Malawi Population-based HIV Impact Assessment survey data.
    PLoS One. 2024;19:e0309053.
    PubMed    
    Abstract available

  275. SUTHERLAND EK, Smith JD, Ofori-Boateng M, Kushitor SB, et al
    Study protocol for the development of a real-time interface showing the availability of breast and cervical cancer services in Ghana.
    PLoS One. 2024;19:e0312150.
    PubMed    
    Abstract available

  276. RONG Y, Yang Y, Zhang X, Zhou X, et al
    Pain scores reduction with the use of ultrasound-guided paracervical nerve block in patients with cervical cancer undergoing intracavitary brachytherapy: A randomized controlled trial.
    PLoS One. 2024;19:e0310238.
    PubMed    
    Abstract available

  277. SULTANOV M, Koot JAR, de Bock GH, Greuter MJW, et al
    High-risk human papillomavirus testing for cervical cancer screening in Uganda: Considering potential harms and benefits in a low-resource setting.
    PLoS One. 2024;19:e0312295.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;